GeneReach Biotechnology Corp. (TPEX:4171)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
19.80
-0.15 (-0.75%)
May 9, 2025, 1:30 PM CST

GeneReach Biotechnology Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
110.27216.77748.61663.43313.68
Upgrade
Short-Term Investments
270.8285.95---
Upgrade
Trading Asset Securities
122.7----
Upgrade
Cash & Short-Term Investments
503.76502.72748.61663.43313.68
Upgrade
Cash Growth
0.21%-32.85%12.84%111.50%77.20%
Upgrade
Accounts Receivable
43.0521.4755.86195.75165.77
Upgrade
Other Receivables
3.371.680.40.720.66
Upgrade
Receivables
46.4223.1456.26196.47166.42
Upgrade
Inventory
37.5267.37235.81268.3237.08
Upgrade
Prepaid Expenses
3.245.888.3634.6831.4
Upgrade
Other Current Assets
3.7233.0121.0317.6650.06
Upgrade
Total Current Assets
594.67632.141,0701,181798.64
Upgrade
Property, Plant & Equipment
359.65433.83436.93397.11385.56
Upgrade
Long-Term Investments
3.24--3.2410.06
Upgrade
Other Intangible Assets
12.412.359.4910.038.84
Upgrade
Long-Term Deferred Tax Assets
83.2177.6535.262427.61
Upgrade
Other Long-Term Assets
13.3320.1870.1569.519.81
Upgrade
Total Assets
1,0661,1761,6221,6841,241
Upgrade
Accounts Payable
7.748.8613.3531.6831.69
Upgrade
Short-Term Debt
171104494951
Upgrade
Current Portion of Long-Term Debt
-35.62204.427.5-
Upgrade
Current Portion of Leases
11.6411.3812.648.547.72
Upgrade
Current Income Taxes Payable
73.5923.0874.4555.94
Upgrade
Current Unearned Revenue
2.934.967.819.435.39
Upgrade
Other Current Liabilities
39.2137.574.887.6293.41
Upgrade
Total Current Liabilities
239.53205.9385.09278.21245.14
Upgrade
Long-Term Debt
--15217.3930
Upgrade
Long-Term Leases
84.5997.74108.8987.3599.19
Upgrade
Long-Term Unearned Revenue
10.578.788.958.82-
Upgrade
Long-Term Deferred Tax Liabilities
6.291.261.281.22.39
Upgrade
Other Long-Term Liabilities
0.020.020.021.640.06
Upgrade
Total Liabilities
341313.71519.23596.35382.75
Upgrade
Common Stock
574.58574.58459.66417.87405.9
Upgrade
Additional Paid-In Capital
144.9144.9144.9144.9272.72
Upgrade
Retained Earnings
-3.29114.74464.44491.74137.95
Upgrade
Comprehensive Income & Other
0.79-2.15-1.33-4.7-3.56
Upgrade
Total Common Equity
716.98832.061,0681,050813.02
Upgrade
Minority Interest
8.5130.3735.0138.2644.74
Upgrade
Shareholders' Equity
725.49862.441,1031,088857.76
Upgrade
Total Liabilities & Equity
1,0661,1761,6221,6841,241
Upgrade
Total Debt
267.23248.74389.95369.78187.91
Upgrade
Net Cash (Debt)
236.53253.98358.66293.65125.78
Upgrade
Net Cash Growth
-6.87%-29.19%22.14%133.48%23.04%
Upgrade
Net Cash Per Share
4.124.426.055.012.19
Upgrade
Filing Date Shares Outstanding
57.0657.4657.4657.4657.46
Upgrade
Total Common Shares Outstanding
57.0657.4657.4657.4657.46
Upgrade
Working Capital
355.14426.24684.99902.32553.5
Upgrade
Book Value Per Share
12.5614.4818.5818.2714.15
Upgrade
Tangible Book Value
704.59819.721,0581,040804.18
Upgrade
Tangible Book Value Per Share
12.3514.2718.4218.1014.00
Upgrade
Buildings
-292.04267.33266.03263.88
Upgrade
Machinery
-309.58273.19231.16171.49
Upgrade
Construction In Progress
--20.95-0.04
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.